HPV vaccine

It’s hard to remember that, at the time it was introduced in 2008, many questions were raised about whether the human papillomavirus (HPV) vaccine would be cost effective. In the intervening decade and a half, it has become abundantly clear…

Ensuring gender-neutral HPV vaccination, more flexible GP access hours, and national cancer plans tackling gender specific needs are among the policies that have been identified to improve male cancer outcomes. The roadmap ‘Time to Accelerate: Action on Men and Cancer’,…

It’s 9.30 in the heart of Kaliro district in eastern Uganda, and a group of women is already gathered outside the Nansololo Health Centre II by the time the van from the Rays of Hope Hospice Jinja arrives. They are…

Vaccinations for human papillomavirus (HPV) in Africa are well below World Health Organisation (WHO) targets due to COVID-19 pandemic disruptions. The WHO Africa region target was to have 35 countries introduce the HPV vaccine by 2020, but only 16 countries…

To prevent pre-invasive cervical disease, a single dose of the human papillomavirus (HPV) vaccine could be enough. Investigation of more than 130,000 young women suggests that 1 dose of quadrivalent (4vHPV) vaccine has the same effectiveness of 2 doses, recommended…